将43例入院患者随机分为2组,在常规治疗基础上,治疗组23例予长春西汀联合弥可保治疗,对照组20例单用弥可保治疗,疗程均为半个月,观察治疗后患者肌电图情况,并行疗效评定。结果:治疗组临床疗效、肌电图的改善情况均明显优于对照组(P均<0.05)。结论:长春西汀联合弥可保治疗糖尿病周围神经病变安全有效,优于单纯弥可保方案。 The 43 patients admitted to hospital were randomly divided into two groups. On the basis of routine treatment, 23 patients in the treatment group were treated with vinpocetine and Mi-Pak, while 20 patients in the control group were treated with Mi-Pak alone. All the patients were treated for half a month. EMG patients after treatment, parallel curative effect evaluation. Results: The clinical efficacy and EMG improvement in the treatment group were significantly better than those in the control group (all P <0.05). Conclusion: Vinpocetine combined with miconazole treatment of diabetic peripheral neuropathy is safe and effective, superior to the simple remedial program.